Skip to main content
. 2020 Jul;21(7):2067–2074. doi: 10.31557/APJCP.2020.21.7.2067

Table 2.

Comparison of Ki67, CD105 (MVD) and α-SMA Expression between OSCC, and OSCC-OSF with Respect to Histopathologicalgrading (HPG)

HPG Biomarkers groups n Mean (SD) P-value
WDSCC Ki67 OSCC 37 45.07 (4.66) 0.018
OSCC-OSF 63 42.93 (5.50)
MVD OSCC 37 73.94 (10.90) <0.001
OSCC-OSF 63 65.63 (8.20)
α-SMA OSCC 37 1.21 (0.85) 0.457
OSCC-OSF 63 1.33 (0.80)
MDSCC Ki67 OSCC 69 59.79 (10.55) 0.48
OSCC-OSF 37 58.71 (8.14)
MVD OSCC 69 85.36 (13.51) 0.905
OSCC-OSF 37 85.78 (11.47)
α-SMA OSCC 69 2.42 (0.69) 0.046
OSCC-OSF 37 2.16 (0.68)
PDSCC Ki67 OSCC 6 76.85 (6.48) 0.361
OSCC-OSF 5 71.87 (11.91)
MVD OSCC 6 101.33 (12.24) 0.714
OSCC-OSF 5 99.00 (13.07)
α-SMA OSCC 6 3.00 (0.00) 1.00
OSCC-OSF 5 3.00 (0.00)

Histopathological grading, HPG; WDSCC, Well differentiated squamous cell carcinoma; MDSCC, Moderately differentiated squamous cell carcinoma; PDSCC, Poorly differentiated squamous cell carcinoma